UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

International journal of clinical practice (Esher), 2013-07, Vol.67 (7), p.619-632

2013

Volltextzugriff (PDF)

DIAGNOSING BLADDER OUTLET OBSTRUCTION IN WOMEN

The Journal of urology, 1999-05, Vol.161 (5), p.1535-1540

1999

Volltextzugriff (PDF)

Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial

International journal of clinical practice (Esher), 2014-08, Vol.68 (8), p.972-985

2014

Volltextzugriff (PDF)

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

Neurourology and urodynamics, 2010-01, Vol.29 (1), p.213-240

2010

Volltextzugriff (PDF)

Long-term efficacy: The Achille's heel of the male sling?

Progrès en urologie (Paris), 2018-03, Vol.28 (4), p.191-192

2018

Volltextzugriff (PDF)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

International journal of clinical practice (Esher), 2014-10, Vol.68 (10), p.1246-1256

2014

Volltextzugriff (PDF)

Validation of Treatment Benefit Scale for Assessing Subjective Outcomes in Treatment of Overactive Bladder

Urology (Ridgewood, N.J.), 2008-10, Vol.72 (4), p.803-807

2008

Volltextzugriff (PDF)

THE ETIOLOGY OF POST-RADICAL PROSTATECTOMY INCONTINENCE AND CORRELATION OF SYMPTOMS WITH URODYNAMIC FINDINGS

The Journal of urology, 1998-10, Vol.160 (4), p.1317-1320

1998

Volltextzugriff (PDF)

PERCUTANEOUS AFFERENT NEUROMODULATION FOR THE REFRACTORY OVERACTIVE BLADDER: RESULTS OF A MULTICENTER STUDY

The Journal of urology, 2001-04, Vol.165 (4), p.1193-1198

2001

Volltextzugriff (PDF)

Is there a role for surgical treatment in patients with Parkinson’s disease and benign prostatic obstruction?

European urology open science (Online), 2020-07, Vol.19, p.e689

2020

Volltextzugriff (PDF)

Does videourodynamic diagnosis of primary bladder neck obstruction in women predict success after bladder neck incision independent of detrusor pressure?

European urology open science (Online), 2020-07, Vol.19, p.e1622

2020

Volltextzugriff (PDF)

Dorsal onlay buccal mucosa vs. vaginal-flap “Blandy” urethroplasty for female stricture: A single-center series

European urology open science (Online), 2020-07, Vol.19, p.e367

2020

Volltextzugriff (PDF)

Sling revision for bladder outlet obstruction in women with primarily storage symptoms: What are the best urodynamic criteria to predict outcomes?

European urology open science (Online), 2020-07, Vol.19, p.e290-e291

2020

Volltextzugriff (PDF)

PREVENTION AND MANAGEMENT OF INCONTINENCE FOLLOWING RADICAL PROSTATECTOMY

Urologic clinics of North America, 2001-08, Vol.28 (3), p.595-612

2001

Volltextzugriff (PDF)

EROSION OF WOVEN POLYESTER PUBOVAGINAL SLING

The Journal of urology, 1999-12, Vol.162 (6), p.2070-2072

1999

Volltextzugriff (PDF)

Correlation of Valsalva Leak Point Pressure with Subjective Degree of Stress Urinary Incontinence in Women

The Journal of urology, 1996, Vol.155 (1), p.281-285

1996

Volltextzugriff (PDF)

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

The Journal of urology, 2013-06, Vol.189 (6), p.2186-2193

2013

Volltextzugriff (PDF)

OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized Trials

Toxicon (Oxford), 2022-07, Vol.214, p.S44-S45

2022

Volltextzugriff (PDF)

Durable improvements in urinary incontinence and positive treatment response in patients with idiopathic overactive bladder syndrome following long-term onabotulinumtoxinA treatment: Final results of 3.5-year study

Progrès en urologie (Paris), 2015-11, Vol.25 (13), p.739-739

2015

Volltextzugriff (PDF)

Obstruction Following Anti-Incontinence Procedures: Diagnosis and Treatment with Transvaginal Urethrolysis

The Journal of urology, 1994-07, Vol.152 (1), p.93-98

1994

Volltextzugriff (PDF)

DYSFUNCTIONAL VOIDING IN WOMEN

The Journal of urology, 2001-01, Vol.165 (1), p.143-148

2001

Volltextzugriff (PDF)

Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions

International journal of clinical practice (Esher), 2005-07, Vol.59 (7), p.825-830

2005

Volltextzugriff (PDF)

Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study

European urology, 2024-03, Vol.85, p.S1782-S1783

2024

Volltextzugriff (PDF)

A0788 - Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study

European urology, 2024-03, Vol.85, p.S1782-S1783

2024

Volltextzugriff (PDF)

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

The Journal of urology, 2017-02, Vol.197 (2), p.S216-S223

2017

Volltextzugriff (PDF)

1 – 25 von 363

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

DIAGNOSING BLADDER OUTLET OBSTRUCTION IN WOMEN

Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

Long-term efficacy: The Achille's heel of the male sling?

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

Validation of Treatment Benefit Scale for Assessing Subjective Outcomes in Treatment of Overactive Bladder

THE ETIOLOGY OF POST-RADICAL PROSTATECTOMY INCONTINENCE AND CORRELATION OF SYMPTOMS WITH URODYNAMIC FINDINGS

PERCUTANEOUS AFFERENT NEUROMODULATION FOR THE REFRACTORY OVERACTIVE BLADDER: RESULTS OF A MULTICENTER STUDY

Is there a role for surgical treatment in patients with Parkinson’s disease and benign prostatic obstruction?

Does videourodynamic diagnosis of primary bladder neck obstruction in women predict success after bladder neck incision independent of detrusor pressure?

Dorsal onlay buccal mucosa vs. vaginal-flap “Blandy” urethroplasty for female stricture: A single-center series

Sling revision for bladder outlet obstruction in women with primarily storage symptoms: What are the best urodynamic criteria to predict outcomes?

PREVENTION AND MANAGEMENT OF INCONTINENCE FOLLOWING RADICAL PROSTATECTOMY

EROSION OF WOVEN POLYESTER PUBOVAGINAL SLING

Correlation of Valsalva Leak Point Pressure with Subjective Degree of Stress Urinary Incontinence in Women

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized Trials

Durable improvements in urinary incontinence and positive treatment response in patients with idiopathic overactive bladder syndrome following long-term onabotulinumtoxinA treatment: Final results of 3.5-year study

Obstruction Following Anti-Incontinence Procedures: Diagnosis and Treatment with Transvaginal Urethrolysis

DYSFUNCTIONAL VOIDING IN WOMEN

Overactive bladder: achieving a differential diagnosis from other lower urinary tract conditions

Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study

A0788 - Device programming, MRI utilization and safety of sacral neuromodulation through 24 months in a global post-market study

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

Aktive Filter

Suchergebnisse filtern